Archives

  • 2026-10
  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • Influenza Hemagglutinin (HA) Peptide: Optimizing Protein ...

    2026-01-02

    Influenza Hemagglutinin (HA) Peptide: Optimizing Protein Detection & Purification Workflows

    Overview: The Principle and Power of the HA Tag Peptide

    The Influenza Hemagglutinin (HA) Peptide (SKU: A6004) is a synthetic nine-amino acid sequence (YPYDVPDYA) derived from the epitope region of the influenza hemagglutinin protein. As a molecular biology peptide tag, its primary value lies in its ability to serve as a robust epitope tag for protein detection, purification, and elution of HA-tagged fusion proteins. The HA tag sequence offers a universal platform for monitoring protein expression, studying protein-protein interactions, and ensuring reliable immunoprecipitation with Anti-HA antibodies.

    In a recent benchmark colorectal cancer study (Dong et al., 2025), epitope tagging strategies were pivotal for dissecting the molecular functions of E3 ligases in vivo. The HA tag’s versatility and compatibility with high-affinity antibodies make it the gold standard for tracking fusion proteins across diverse systems. APExBIO’s HA peptide stands out for its purity (>98%, confirmed by HPLC and MS) and exceptional solubility (≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol, ≥46.2 mg/mL in water), enabling seamless integration into a range of buffer systems and assay formats.

    Step-by-Step: Enhancing Immunoprecipitation and Elution Protocols

    1. Sample Preparation and Lysis

    • Cell Harvesting: Collect cells expressing the HA-tagged protein of interest. Use optimized lysis buffers (e.g., RIPA, NP-40) compatible with downstream immunoprecipitation to maintain protein integrity.
    • Clarification: Centrifuge lysates at high speed (≥12,000 g, 10 min) to remove debris and non-specific aggregates.

    2. Immunoprecipitation with Anti-HA Antibody

    • Bead Selection: Incubate clarified lysate with anti-HA magnetic beads or sepharose-conjugated anti-HA antibody. The high specificity of anti-HA reagents ensures selective capture of HA fusion proteins.
    • Washing: Perform multiple washes with buffer containing 0.1–0.5% detergent to minimize background while preserving genuine protein-protein interactions.

    3. Competitive Elution Using HA Peptide

    • Elution Principle: Add the Influenza Hemagglutinin (HA) Peptide (final concentration: 0.2–1 mg/mL) directly to the bead-bound complexes. The peptide competitively binds to the anti-HA antibody, displacing the HA-tagged protein under native conditions.
    • Incubation: Gently agitate for 30–60 minutes at 4°C. Elution efficiency can reach >95% with optimized peptide concentration and buffer conditions (see scenario-driven solutions).
    • Collection: Recover the supernatant containing the eluted HA fusion protein for downstream analysis (e.g., SDS-PAGE, Western blot, mass spectrometry).

    This workflow is supported by performance data from APExBIO and independent studies, demonstrating that high-purity, highly soluble HA tag peptide enables reproducible protein recovery and minimizes antibody contamination in eluates.

    Advanced Applications and Comparative Advantages

    Protein-Protein Interaction Studies

    As highlighted in this machine-readable reference, the HA epitope tag is invaluable for dissecting protein complexes and transient interactions. Its small size (9 amino acids) reduces steric hindrance compared to larger tags, preserving native protein function and localization. By using the HA tag DNA sequence or integrating the HA tag nucleotide sequence into expression constructs, researchers can rapidly generate fusion proteins for interactome mapping or pathway elucidation.

    Comparative Advantages Over Other Tags

    • Specificity: The influenza hemagglutinin epitope is rare in endogenous proteins, minimizing cross-reactivity in mammalian, yeast, and insect systems.
    • Solubility and Purity: Quantitative recovery is enabled by the peptide’s high solubility and confirmed purity (see comparative analysis), supporting sensitive detection even in complex lysates.
    • Reproducibility: The competitive binding to Anti-HA antibody allows for gentle, non-denaturing elution—a critical advantage for downstream functional assays and mass spectrometry.

    Integration in High-Throughput and Challenging Workflows

    For labs handling multiple samples or working with low-abundance targets, the HA tag's reliability is a game-changer. As detailed in peer-reviewed scenarios, the HA peptide supports high-throughput immunoprecipitation, chromatin immunoprecipitation (ChIP), and advanced exosome studies, delivering consistent performance across platforms.

    Troubleshooting and Optimization: Maximizing Recovery and Specificity

    Common Challenges and Practical Solutions

    • Low Elution Yield: Increase HA peptide concentration incrementally up to 2 mg/mL. Ensure adequate incubation time and gentle mixing to maximize competitive displacement.
    • Antibody Contamination: The competitive elution strategy with HA peptide reduces antibody leaching compared to harsh elution buffers. Always pre-wash beads thoroughly and use fresh aliquots of peptide for each experiment.
    • Non-Specific Binding: Include 0.1–0.5% non-ionic detergents (e.g., Tween-20, NP-40) during washes. Pre-clearing lysates with control beads can further decrease background.
    • Peptide Stability: Store lyophilized HA peptide desiccated at -20°C. Prepare fresh working solutions immediately before use to preserve activity, as recommended by APExBIO.

    Quantitative Tips for Reproducibility

    • Use a minimum of 0.5 mg HA peptide per immunoprecipitation to achieve >90% recovery, as validated in high-throughput protein-protein interaction studies (see quantitative recovery data).
    • Optimize buffer composition (pH 7.4–8.0, physiological salt) to maintain native protein interactions during elution.
    • Validate each new lot of peptide with a control immunoprecipitation to confirm activity and rule out batch variability.

    Future Outlook: HA Tag Peptide in Precision Research

    Emerging studies such as Dong et al., 2025 illustrate the increasing reliance on robust epitope tag systems for dissecting molecular mechanisms in disease models. As functional genomics and interactome mapping expand, the need for high-fidelity, validated tags like the Influenza Hemagglutinin (HA) Peptide will only grow. APExBIO’s commitment to quality—delivering lot-to-lot consistency and analytical documentation—positions this product as a cornerstone for next-generation molecular biology, proteomics, and therapeutic research.

    For detailed workflow comparisons and scenario-driven troubleshooting, researchers are encouraged to consult the following resources:

    Whether your focus is basic research, translational discovery, or advanced proteomics, the HA tag peptide remains an indispensable tool. With APExBIO’s Influenza Hemagglutinin (HA) Peptide, you can trust in reproducibility, sensitivity, and flexibility for every stage of your protein analysis pipeline.